NCT00047840View on ClinicalTrials.gov

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

September 30, 2006

Conditions
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
Interventions
DRUG

ZD6474

DRUG

Placebo

DRUG

Docetaxel

Trial Locations (26)

Unknown

Research Site, Los Angeles

Research Site, Jacksonville

Research Site, Atlanta

Research Site, New Orleans

Research Site, Boston

Research Site, Pittsfield

Research Site, Ann Arbor

Research Site, Detroit

Research Site, Billings

Research Site, Great Neck

Research Site, New York

Research Site, Durham

Research Site, Coos Bay

Research Site, Philadelphia

Research Site, Pittsburgh

Research Site, Houston

Research Site, Brno

Research Site, Chomutov

Research Site, Hradec

Research Site, Ostrava

Research Site, Pilsen

Research Site, Prague

Research Site, Budapest

Research Site, Debrecen

Research Site, Deszk

Research Site, Törökbálint

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00047840 - This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. | Biotech Hunter | Biotech Hunter